Shire to Forest on Deal List for AstraZeneca: Real M&A

For AstraZeneca Plc to reverse its worst profit slide, the drugmaker needs to make its biggest purchase since at least 2007.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.